Major cancer registry tracks rare thyroid cancer to guide future treatments
NCT ID NCT04216732
Summary
This study aims to better understand how advanced medullary thyroid cancer develops and affects patients over time. Researchers will use a large existing patient registry and ask about 2,030 participants to complete regular questionnaires about their health, quality of life, and treatment experiences. The goal is to gather detailed information to help doctors manage this rare cancer more effectively in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.